Amanita species contain potent hepatotoxins that can cause acute liver failure through massive hepatic necrosis. Before modern transplant protocols were widely available, mortality from Amanita poisoning was extremely high.
Research published in the Journal of Orthomolecular Medicine (1998; 13[1]:44–48) described the treatment of a patient with severe hepatic necrosis following ingestion of toxic mushrooms. The patient received intravenous alpha-lipoic acid within approximately 30 hours of ingestion. According to the report, clinical improvement began within an hour of treatment.
Earlier data presented by Dr. Burton Berkson at the International Amanita Symposium (1980; pp. 197–202) summarized outcomes in 75 patients treated with intravenous alpha-lipoic acid following amanita poisoning. Of these patients:
-
67 recovered fully
-
8 died
Importantly, outcomes were strongly time-dependent. Shorter intervals between mushroom ingestion and initiation of IV alpha-lipoic acid were associated with better survival, suggesting a narrow therapeutic window.
